-+ 0.00%
-+ 0.00%
-+ 0.00%

The Tokyo Stock Exchange saw Qualips, a regenerative medicine company, indicated to hit the daily limit high following the world's first practical application of iPS cell-derived cardiomyocyte sheets.

NIKKEI QUICK·09/30/2026 01:39:02

Please log in to view news